Search results
Auris Medical stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Real time Altamira Therapeutics (EARS) stock price quote, stock graph, news & analysis.
Stock analysis for Altamira Therapeutics Ltd (EARS:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial...
EARS -- Is Its Stock Price A Worthy Investment? Learn More. Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. The company was formerly known as Auris Medical AG and changed its name to Auris Medical Holding AG in April 2014.
You can watch EARS and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Auris Medical against related stocks people have also bought.
Undervalued by 127.1 % based on the discounted cash flow analysis. Auris Medical is a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders. The Company is focused on the development of intranasal be...
